125 related articles for article (PubMed ID: 9923456)
1. Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: a pilot study.
Mapara MY; Körner IJ; Lentzsch S; Krahl D; Reichardt P; Dörken B
Exp Hematol; 1999 Jan; 27(1):169-75. PubMed ID: 9923456
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B
Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer.
Preti RA; Lazarus HM; Winter J; Stadtmauer EA; Nadasi S; McMannis J; Karandish S; Jennis A; Goldberg SL; Pecora AL
Cytotherapy; 2001; 3(2):85-95. PubMed ID: 12028831
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation.
Cancelas JA; Querol S; Canals C; Picón M; Azqueta C; Solà C; Montes A; Amill B; Griera E; Inglés J; López JJ; Germà JR; García-López J
Transfusion; 1998; 38(11-12):1063-70. PubMed ID: 9838939
[TBL] [Abstract][Full Text] [Related]
6. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
Han X; Shi Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
[TBL] [Abstract][Full Text] [Related]
7. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
8. Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content.
Voso MT; Hohaus S; Moos M; Pförsich M; Cremer FW; Schlenk RF; Martin S; Hegenbart U; Goldschmidt H; Haas R
Br J Haematol; 1999 Feb; 104(2):382-91. PubMed ID: 10050723
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer.
Hohaus S; Pförsich M; Murea S; Abdallah A; Lin YS; Funk L; Voso MT; Kaul S; Schmid H; Wallwiener D; Haas R
Br J Haematol; 1997 Jun; 97(4):881-8. PubMed ID: 9217192
[TBL] [Abstract][Full Text] [Related]
10. Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia.
Martin H; Atta J; Zumpe P; Eder M; Elsner S; Rode C; Wassmann B; Bruecher J; Hoelzer D
Exp Hematol; 1995 Dec; 23(14):1612-8. PubMed ID: 8542955
[TBL] [Abstract][Full Text] [Related]
11. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device.
Després D; Flohr T; Uppenkamp M; Baldus M; Hoffmann M; Huber C; Derigs HG
J Hematother Stem Cell Res; 2000 Aug; 9(4):557-64. PubMed ID: 10982256
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
Mohr M; Dalmis F; Hilgenfeld E; Oelmann E; Zühlsdorf M; Kratz-Albers K; Nolte A; Schmitmann C; Onaldi-Mohr D; Cassens U; Serve H; Sibrowski W; Kienast J; Berdel WE
Clin Cancer Res; 2001 Jan; 7(1):51-7. PubMed ID: 11205918
[TBL] [Abstract][Full Text] [Related]
13. Isolation and transplantation of highly purified autologous peripheral CD34+progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan.
Chou T; Sano M; Ogura M; Morishima Y; Itagaki H; Tokuda Y
Breast Cancer; 2005; 12(3):178-88. PubMed ID: 16110287
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
15. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
Bone Marrow Transplant; 1997 Sep; 20(5):415-20. PubMed ID: 9339759
[TBL] [Abstract][Full Text] [Related]
16. Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
Kvalheim G; Wang MY; Pharo A; Holte H; Jacobsen E; Beiske K; Kvaløy S; Smeland E; Funderud S; Fodstad O
J Hematother; 1996 Aug; 5(4):427-36. PubMed ID: 8877718
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia.
Dreger P; Viehmann K; von Neuhoff N; Krüss D; Glass B; Kneba M; Mitsky P; Jopp P; Rautenberg P; Mills B; Schmitz N
Exp Hematol; 2000 Oct; 28(10):1187-96. PubMed ID: 11027838
[TBL] [Abstract][Full Text] [Related]
18. CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Papadopoulos KP; Ayello J; Reiss RF; Troxel A; Kaufman E; Vahdat LT; Antman KH; Hesdorffer CS
J Hematother Stem Cell Res; 1999 Aug; 8(4):357-63. PubMed ID: 10634173
[TBL] [Abstract][Full Text] [Related]
19. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
[TBL] [Abstract][Full Text] [Related]
20. Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas.
Pichert G; Schmitter D; Widmer L; Jost LM; Kurrer MO; Maurer R; Stahel RA
Ann Oncol; 1998 Jan; 9(1):51-4. PubMed ID: 9541683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
